News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
733,781 Results
Type
Article (46485)
Company Profile (316)
Press Release (686980)
Multimedia
Podcasts (91)
Webinars (12)
Section
Business (214302)
Career Advice (2304)
Deals (37480)
Drug Delivery (116)
Drug Development (84967)
Employer Resources (181)
FDA (16873)
Job Trends (15751)
News (363493)
Policy (34852)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (9)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (6)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (6)
2025 BioForest Digital (5)
2025 Lone Star Bio Digital (6)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2732)
Academic (1)
Accelerated approval (5)
Adcomms (26)
Allergies (86)
Alliances (52604)
ALS (92)
Alzheimer's disease (1411)
Antibody-drug conjugate (ADC) (131)
Approvals (16859)
Artificial intelligence (261)
Autoimmune disease (25)
Automation (14)
Bankruptcy (380)
Best Places to Work (11952)
BIOSECURE Act (20)
Biosimilars (115)
Biotechnology (198)
Bladder cancer (62)
Brain cancer (28)
Breast cancer (264)
Cancer (2139)
Cardiovascular disease (183)
Career advice (1918)
Career pathing (33)
CAR-T (154)
Cell therapy (421)
Cervical cancer (20)
Clinical research (68841)
Collaboration (823)
Compensation (503)
Complete response letters (28)
COVID-19 (2729)
CRISPR (44)
C-suite (230)
Cystic fibrosis (103)
Data (2054)
Decentralized trials (2)
Denatured (29)
Depression (45)
Diabetes (271)
Diagnostics (6526)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (121)
Drug pricing (117)
Drug shortages (32)
Duchenne muscular dystrophy (92)
Earnings (88828)
Editorial (38)
Employer branding (22)
Employer resources (155)
Events (117055)
Executive appointments (695)
FDA (18052)
Featured Employer (53)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (733)
Gene editing (109)
Generative AI (25)
Gene therapy (310)
GLP-1 (783)
Government (4647)
Grass and pollen (4)
Guidances (50)
Healthcare (19446)
Huntington's disease (23)
IgA nephropathy (28)
Immunology and inflammation (125)
Indications (27)
Infectious disease (2878)
Inflammatory bowel disease (143)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (93)
Interviews (370)
IPO (17012)
IRA (48)
Job creations (4228)
Job search strategy (1641)
Kidney cancer (10)
Labor market (34)
Layoffs (502)
Leadership (21)
Legal (8635)
Liver cancer (73)
Lung cancer (310)
Lymphoma (140)
Machine learning (4)
Management (63)
Manufacturing (299)
MASH (67)
Medical device (13620)
Medtech (13625)
Mergers & acquisitions (20969)
Metabolic disorders (719)
Multiple sclerosis (77)
NASH (21)
Neurodegenerative disease (97)
Neuropsychiatric disorders (30)
Neuroscience (1950)
NextGen: Class of 2025 (6850)
Non-profit (4674)
Northern California (2512)
Now hiring (37)
Obesity (393)
Opinion (250)
Ovarian cancer (75)
Pain (90)
Pancreatic cancer (80)
Parkinson's disease (151)
Partnered (20)
Patents (223)
Patient recruitment (101)
Peanut (50)
People (60396)
Pharmaceutical (98)
Pharmacy benefit managers (21)
Phase I (21396)
Phase II (30230)
Phase III (22692)
Pipeline (1118)
Policy (139)
Postmarket research (2739)
Preclinical (9030)
Press Release (69)
Prostate cancer (98)
Psychedelics (31)
Radiopharmaceuticals (254)
Rare diseases (396)
Real estate (6451)
Recruiting (69)
Regulatory (23670)
Reports (47)
Research institute (2457)
Resumes & cover letters (382)
Rett syndrome (4)
RNA editing (4)
RSV (46)
Schizophrenia (74)
Series A (127)
Series B (82)
Service/supplier (15)
Sickle cell disease (54)
Southern California (2170)
Special edition (17)
Spinal muscular atrophy (154)
Sponsored (29)
Startups (3855)
State (2)
Stomach cancer (15)
Supply chain (69)
Tariffs (19)
The Weekly (60)
United States (22135)
Vaccines (712)
Venture capitalists (37)
Weight loss (280)
Women's health (35)
Worklife (17)
Date
Today (80)
Last 7 days (486)
Last 30 days (2625)
Last 365 days (34227)
2025 (9024)
2024 (36345)
2023 (41179)
2022 (52380)
2021 (56996)
2020 (55560)
2019 (48480)
2018 (36666)
2017 (34025)
2016 (33726)
2015 (39549)
2014 (33435)
2013 (28592)
2012 (30712)
2011 (31378)
2010 (29344)
Location
Africa (843)
Alabama (51)
Alaska (7)
Arizona (236)
Arkansas (14)
Asia (42381)
Australia (6850)
California (5735)
Canada (1928)
China (506)
Colorado (255)
Connecticut (263)
Delaware (137)
Europe (92013)
Florida (862)
Georgia (206)
Idaho (58)
Illinois (533)
India (25)
Indiana (314)
Iowa (9)
Japan (152)
Kansas (102)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (874)
Massachusetts (4359)
Michigan (218)
Minnesota (384)
Mississippi (2)
Missouri (80)
Montana (27)
Nebraska (25)
Nevada (58)
New Hampshire (62)
New Jersey (1657)
New Mexico (31)
New York (1643)
North Carolina (994)
North Dakota (7)
Northern California (2512)
Ohio (197)
Oklahoma (14)
Oregon (39)
Pennsylvania (1299)
Puerto Rico (11)
Rhode Island (29)
South America (1219)
South Carolina (19)
South Dakota (1)
Southern California (2170)
Tennessee (97)
Texas (857)
Utah (172)
Virginia (145)
Washington D.C. (60)
Washington State (538)
West Virginia (3)
Wisconsin (52)
733,781 Results for "catalyst pharma group inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan
January 21, 2025
·
4 min read
Press Releases
LSL PHARMA GROUP ANNOUNCES THE SIGNING OF TWO AGREEMENTS TO MARKET NEW OPHTHALMIC PRODUCTS IN CANADA
April 3, 2025
·
1 min read
Business
Five Biggest Drug Face-Offs in Pharma History
Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of rivalry that includes blockbuster drugs Keytruda, Humira and Eliquis.
April 9, 2025
·
9 min read
·
Tristan Manalac
Press Releases
Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals
April 9, 2025
·
5 min read
LSL Pharma Group Completes the Acquisition of Virage Santé
LSL PHARMA GROUP INC., a Canadian integrated pharmaceutical company, is pleased to announce the completion of the acquisition of Virage Santé, a company specializing in the manufacturing and marketing of natural health products, based in Lévis, Quebec.
June 18, 2024
·
3 min read
Government
Trump Tariffs Miss Pharma For Now, But Uncertainties Loom
Pharma’s reprieve from Donald Trump’s tariffs is expected to be temporary, with Leerink analysts anticipating possible sector-specific duties “in the next month or so.”
April 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference
March 4, 2025
·
2 min read
Business
LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders
LSL PHARMA GROUP INC., a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholders held in Montréal, Québec.
June 28, 2024
·
3 min read
Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024
Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX) today announced that Richard J. Daly, President and CEO of Catalyst, along with other members of Catalyst’s management team, will participate at the upcoming Jefferies Global Healthcare Conference 2024 on Wednesday, June 5, 2024, in New York.
May 28, 2024
·
3 min read
Press Releases
Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
February 27, 2025
·
17 min read
1 of 73,379
Next
